4D Molecular Therapeutics, Inc.

NASDAQ:FDMT

5.04 (USD) • At close January 15, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q1
Operating Activities:
Net Income -43.843-34.953-32.401-32.283-10.256-29.616-28.682-27.379-25.691-28.086-26.338-25.083-22.239-7.589-16.406-20.547-7.833-15.153-13.16-16.115-16.675-8.258-8.258-2.183-2.183-2.593-2.593
Depreciation & Amortization 1.7031.6241.5941.5131.3961.4281.4121.3880.8790.8310.7821.8870.3820.370.3810.3710.3690.3590.3440.3180.280.2030.2030.1780.1780.1710.171
Deferred Income Tax 000-0.63000000000.007-0.0070.094000000000000
Stock Based Compensation 6.496.0735.9745.9134.5624.9694.2214.3464.524.3223.9333.7313.9233.8162.3291.7171.1471.0371.0831.0151.0540.7360.7360.4870.4870.2020.202
Change In Working Capital 4.208-0.688-3.520.6643.0981.359-4.491-0.358-0.9772.537-2.538-3.1092.184-12.817-1.7920.908-7.0597.59-2.153.441-0.6460.0280.0280.2530.253-0.567-0.567
Accounts Receivables 00000000.047000.0470.7440.427-0.2530.521-0.59-0.1680.1510.099-0.080.263-0.019-0.0190.3060.306-0.708-0.708
Change In Inventory 00000000000.314-5.8671.5820.426-0.677-1.531-2.5912.7610.773.864-1.03000000
Change In Accounts Payables -0.508-0.7860.703-1.0881.370.947-0.3331.513-1.6970.226-1.681.6620.7950.429-0.6010.567-2.7752.584-0.3330.708-0.237000000
Other Working Capital 4.7160.098-4.2231.7521.7280.412-4.158-1.9180.722.311-1.219-5.5150.962-12.993-1.7120.931-4.1164.855-1.9162.813-0.6720.0460.046-0.053-0.0530.1410.141
Other Non Cash Items 2.051-2.2997.7240.1730.029-0.205-0.366-0.2110.2520.4920.6110.7380.0290.0150.1160.0520.005-0.0020.0132.6555.13-1.293-1.293-3.651-3.651-0.423-0.423
Operating Cash Flow -29.391-30.243-29.088-24.65-1.171-22.065-27.906-22.214-21.017-19.904-23.55-21.836-15.721-16.205-15.372-17.499-13.371-6.169-13.87-8.686-10.857-8.584-8.584-4.915-4.915-3.211-3.211
Investing Activities:
Investments In Property Plant And Equipment 1.059-0.349-0.71-0.549-0.405-0.805-1.012-1.093-1.964-2.066-6.413-5.096-2.635-0.737-0.642-0.5080.349-0.12-0.721-0.477-1.064-0.831-0.831-0.191-0.191-0.017-0.017
Acquisitions Net 00049.0810-50.0931.01211.536-17.335-59.53400000000000000000
Purchases Of Investments -35.79-96.76-277.324-34.6460-5.427-14.729100.508-187.942-6.185-59.694-32.195-136.37500000000000000
Sales Maturities Of Investments 64.86923.5714.77628.51330.38655.5258.871-135.194205.27765.71911.9975000000000000000
Other Investing Activites -2.8370-0.71-49.08130.38650.093-1.012-11.53617.33559.534-47.6975-136.3750-0.642-100000000000
Investing Cash Flow 27.301-73.539-263.258-6.68229.98149.28843.13-35.77915.37157.468-54.11-32.291-139.01-0.737-0.642-0.5080.349-0.12-0.721-0.477-1.064-0.831-0.831-0.191-0.191-0.017-0.017
Financing Activities:
Debt Repayment 000000000000000000000000000
Common Stock Issued 0.00115.692315.7190.0018.976129.729.6472.730.46-0.050.629116.1391.9770.82-0.847205.1010000.0550000000
Common Stock Repurchased 000000000000000000000000000
Dividends Paid 000000000000000000000000000
Other Financing Activities 0.5671.5573.1134.7611.5810.7991.3472.0460.46-0.050.629116.1391.9770.82-0.8470.8770.972.494-0.389-0.725-1.463-0.031-0.03142.27942.2790.010.01
Financing Cash Flow 0.56817.249318.8324.76210.557130.51910.9942.0460.46-0.050.629116.1391.9770.82-0.847205.9780.972.494-0.389-0.67-1.463-0.031-0.03142.27942.2790.010.01
Other Information:
Effect Of Forex Changes On Cash 000000000000000000000000000
Net Change In Cash -1.522-86.533-0.084-26.5739.367157.74226.218-55.947-5.18637.514-77.03162.012-152.754-16.122-16.861187.971-12.12266.205-14.98-9.833-13.384-9.446-9.44637.17337.173-3.218-3.218
Cash At End Of Period 187.539189.061275.594249.108275.678236.31178.56952.351108.298113.48475.97153.00190.989243.743259.865276.72688.755100.87734.67249.65259.485-9.446-9.44637.17354.58817.415-3.218